AptarGroup, Inc.（ATR）財務資料ATRAptarGroup, Inc.

AptarGroup, Inc. (ATR) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Aptar Pharma, accounting for 44.6% of total sales, equivalent to $458.17M. Other significant revenue streams include Aptar Beauty and Aptar Closures. Understanding this composition is critical for investors evaluating how ATR navigates market cycles within the Non-Paper Containers & Packaging industry.

Evaluating the bottom line, AptarGroup, Inc. maintains a gross margin of 27.85%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 12.89%, while the net margin is 8.57%. These profitability ratios, combined with a Return on Equity (ROE) of 13.61%, provide a clear picture of how effectively ATR converts its operational activities into shareholder value.

In the context of the broader market, ATR competes directly with industry leaders such as OC and SON. With a market capitalization of $8.05B, it holds a significant position in the sector. When comparing efficiency, ATR's gross margin of 27.85% stands against OC's 29.10% and SON's 19.85%. Such benchmarking helps identify whether AptarGroup, Inc. is trading at a premium or discount relative to its financial performance.

Aptargroup's revenue has shown consistent growth, with Q2 2026 revenue at $1.03 billion, up from $961 million in Q3 2025. The gross margin has been stable around 27-30%, indicating solid profitability. The net income for Q2 2026 was $87.57 million, reflecting a recovery from previous quarters.